NBDC Research ID: hum0005.v8

 

SUMMARY

Aims: To identify the causative gene mutation of hearing impairment including non-syndromic hearing loss, syndromic hearing loss, and inner, middle, outer ear malformation.

Methods: Massively Parallel DNA Sequencing was performed with an Ion Torrent Personal Genome Machine (PGM), Ion Proton or Ion S5 system using the Ion PGM 200, Proton HiQ Sequencing Kit and Ion 318 Chip or Ion P1 chip (Thermo Fisher Scientific) or 540 chip chef kit (S5) or HiSeq 2000 system (Illumina).

Participants/Materials: Usher Syndrome: 17 patients

                Non-usher syndrome: 39 patients (Controlled-access) + 5 patients (Unrestricted-access) + 19 patients (Controlled-access) + 19 patients (Controlled-access) + 39 patients (Controlled-access) + 1 patient (Controlled-access) + 28 patients (Controlled-access) + 7 patient (Controlled-access) + 26 patients (Controlled-access) + 15 patients (Controlled-access) + 2969 patients (Controlled-access)

 

Dataset IDType of DataCriteriaRelease Date
DRA001273 NGS (Target Capture: Nine genes) Unrestricted-access 2014/01/27
JGAS000032 NGS (Target Capture) Controlled-access (Type I) 2017/02/24
DRA003791 NGS (Target Capture) Unrestricted-access 2017/02/24
JGAS000093 NGS (Target Capture) Controlled-access (Type I) 2017/06/19
JGAS000123

NGS (Target Capture)

69 genes90 genes

Controlled-access (Type I) 2018/02/13
JGAS000166

NGS (Target Capture)

69 genes90 genes

Controlled-access (Type I) 2019/04/18
JGAS000191 NGS (Target Capture) Controlled-access (Type I) 2021/07/30
JGAS000192

NGS (Target Capture)

69 genes63 genes90 genes

Controlled-access (Type I) 2021/07/30
JGAS000200 NGS (Target Capture) Controlled-access (Type I) 2021/07/30
JGAS000201

NGS (Target Capture)

69 genes63 genes90 genes

Controlled-access (Type I) 2021/07/30
JGAS000323

NGS (Target Capture)

69 genes63 genes90 genes

Controlled-access (Type I) 2021/11/19
JGAS000490

NGS (Target Capture)

69 genes63 genes

Controlled-access (Type I) 2023/10/02

*Release Note 

*Data users need to apply an application for Using NBDC Human Data to reach the Controlled-access Data. Learn more

*When the research results including the data which were downloaded from NHA/DRA, are published or presented somewhere, the data user must refer the papers which are related to the data, or include in the acknowledgment. Learn more

 

MOLECULAR DATA

DRA001273

Participants/Materials 17 usher syndrome patients
Targets Target Capture
Target Loci for Capture Methods

Nine genes

(MYO7A, USH1C, CDH23, PCDH15, SANS[USH1G],

USH2A, GPR98[USH2C], DFNB31[USH2D], CLRN[USH3A])

Platform Thermo Fisher Scientific [Ion PGM]
Library Source gDNA extracted from peripheral blood cells
Cell Lines -
Library Construction (kit name) Ion AmpliSeq Custom kit
Fragmentation Methods -
Spot Type Single-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 200 bp
DDBJ Sequence Read Archive ID DRA001273
Total Data Volume 726.6 MB
Comments (Policies) NBDC policy

 

JGAS000032, JGAS000093, JGAS000123, JGAS000166, JGAS000191, JGAS000192, JGAS000201, JGAS000323, JGAD000490

Participants/Materials

39 non-syndromic hearing loss patients (JGAS000032)

19 non-syndromic hearing loss patients (JGAS000093)

16 non-syndromic hearing loss patients (JGAS000123)

37 non-syndromic hearing loss patients (JGAS000166)

1 non-syndromic hearing loss patient (JGAS000191)

9 non-syndromic hearing loss patients (JGAS000192) (a data from the same patient is included in JGAS000032)

7 non-syndromic hearing loss patients (JGAS000201)

3 non-syndromic hearing loss patients (JGAS000323)

1410 non-syndromic hearing loss patients (JGAS000490)

(ICD10: H90)

Targets Target Capture
Target Loci for Capture Methods

69 genes

(ACTG1, CCDC50, CDH23, CEACAM16, CLDN14, COCH,

COL11A2, CRYM, DFNA5, DFNB59, DIAPH1, ESPN, ESRRB,

EYA4, GIPC3, GJB2, GJB3, GJB6, GPSM2, GRHL2, GRXCR1,

HGF, ILDR1, KCNQ4, LHFPL5, LOXHD1, LRTOMT, MARVELD2,

MIRN96, MSRB3, MYH14, MYH9, MYO15A, MYO1A, MYO3A,

MYO6, MYO7A, OTOA, OTOF, PCDH15, POU3F4, POU4F3,

PRPS1, PTPRQ, RDX, SERPINB6, SLC17A8, SLC26A4,

SLC26A5, SMAC, SMPX, STRC, TECTA, TJP2, TMC1, TMIE,

TMPRSS3, TPRN, TRIOBP, USH1C, USH2A, WFS1, WHRN)

Platform Thermo Fisher Scientific [Ion PGM, Ion Proton]
Library Source gDNA extracted from peripheral blood cells
Cell Lines -
Library Construction (kit name) Ion AmpliSeq Custom kit, Ion AmpliSeq Library Kit ver 2.0
Fragmentation Methods -
Spot Type Single-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 200 bp
DDBJ Sequence Read Archive ID

JGAD000032

JGAD000093

JGAD000134

JGAD000244

JGAD000274

JGAD000275

JGAD000286

JGAD000434

JGAD000607

Total Data Volume

JGAD000032 : 13.73 GB (fastq)

JGAD000093 : 6 GB (fastq)

JGAD000134 : 18 GB (fastq)

JGAD000244 : 18 GB (fastq)

JGAD000274:292 MB(fastq)

JGAD000275:14.3 GB(fastq)

JGAD000286:57 GB(fastq)

JGAD000434:8.8 GB(fastq)

JGAD000607:1.1 TB(fastq)

Comments (Policies) NBDC policy

 

DRA003791

Participants/Materials 5 non-syndromic hearing loss patients (ICD10: H90)
Targets Target Capture
Target Loci for Capture Methods

69 genes

(ACTG1, CCDC50, CDH23, CEACAM16, CLDN14, COCH,

COL11A2, CRYM, DFNA5, DFNB59, DIAPH1, ESPN, ESRRB,

EYA4, GIPC3, GJB2, GJB3, GJB6, GPSM2, GRHL2, GRXCR1,

HGF, ILDR1, KCNQ4, LHFPL5, LOXHD1, LRTOMT, MARVELD2,

MIRN96, MSRB3, MYH14, MYH9, MYO15A, MYO1A, MYO3A,

MYO6, MYO7A, OTOA, OTOF, PCDH15, POU3F4, POU4F3,

PRPS1, PTPRQ, RDX, SERPINB6, SLC17A8, SLC26A4,

SLC26A5, SMAC, SMPX, STRC, TECTA, TJP2, TMC1, TMIE,

TMPRSS3, TPRN, TRIOBP, USH1C, USH2A, WFS1, WHRN)

Platform Thermo Fisher Scientific [Ion PGM]
Library Source gDNA extracted from peripheral blood cells
Cell Lines -
Library Construction (kit name) Ion AmpliSeq Custom Panel, Ion AmpliSeq Library Kit ver 2.0
Fragmentation Methods -
Spot Type Single-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 200 bp
DDBJ Sequence Read Archive ID DRA003791
Total Data Volume 412.5 MB (fastq)
Comments (Policies) NBDC policy

 

JGAS000123, JGAS000166, JGAS000192, JGAS000201, JGAS000323

Participants/Materials

3 non-syndromic hearing loss patients (JGAS000123)

2 non-syndromic hearing loss patients (JGAS000166)

2 non-syndromic hearing loss patients (JGAS000192)

4 non-syndromic hearing loss patients (JGAS000201)

1 non-syndromic hearing loss patients (JGAS000323)

(ICD10: H90)

Targets Target Capture
Target Loci for Capture Methods

90 genes

(ACTG1, AIFM1, ALMS1, ATP2B2, CABP2, CACNA1D, CATSPER2,

CCDC50, CDH23, CEACAM16, CIB2, CLDN14, CLRN1, COCH,

COL11A2, CRYL1, CRYM, DFNA5, DIABLO, DIAPH1, DSPP, ESPN,

ESSRB, EYA1, EYA4, FOXI1, GIPC3, GJB2, GJB3, GJB6, GPR98,

GPSM2, GRHL2, GRXCR1, HGF, ILDR1, KCNJ10, KCNQ1, KCNQ4,

LHFPL5, LOXHD1, LRTOMT, MARVELD2, MSRB3, MYH14, MYH9,

MYO15A, MYO1A, MYO3A, MYO6, MYO7A, OTOA, OTOF, OTOG,

OTOGL, P2RX2, PCDH15, PDZD7, PJVK, PNPT1, POU3F4,

POU4F3, PRPS1, PTPRQ, RDX, SERPINB6, SIX1, SLC17A8,

SLC26A4, SLC26A5, SMPX, STRC, TECTA, TJP2, TMC1, TMIE,

TMPRSS3, TPRN, TRIOBP, TSPEAR, USH1C, USH1G, USH2A,

WFS1, WHRN, MIR96, MIR182, MIR183, MTRNR1, MTTS1)

Platform Illumina [HiSeq 2000]
Library Source gDNA extracted from peripheral blood cells
Cell Lines -
Library Construction (kit name) Agilent Sure Select XT
Fragmentation Methods -
Spot Type Paired-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 100 bp
DDBJ Sequence Read Archive ID

JGAD000134

JGAD000244

JGAD000275

JGAD000286

JGAD000434

Total Data Volume

JGAD000134 : 18 GB (fastq)

JGAD000244 : 18 GB (fastq)

JGAD000275:14.3 GB(fastq)

JGAD000286:57 GB(fastq)

JGAD000434:8.8 GB(fastq)

Comments (Policies) NBDC policy

 

JGAS000192, JGAS000200, JGAS000201, JGAS000323, JGAD000490

Participants/Materials

17 non-syndromic hearing loss patients (JGAS000192)

7 non-syndromic hearing loss patients (JGAS000200)

15 non-syndromic hearing loss patients (JGAS000201)

11 non-syndromic hearing loss patients (JGAS000323)

1559 non-syndromic hearing loss patients (JGAS000490)

(ICD10: H90)

Targets Target Capture
Target Loci for Capture Methods

63 genes

(ACTG1, CCDC50, CDH23, CEACAM16, CLDN14, COCH,

COL11A2, CRYM, DFNA5, DFNB59, DIAPH1, ESPN, ESRRB,

EYA4, GIPC3, GJB2, GJB3, GJB6, GPSM2, GRHL2, GRXCR1,

HGF, ILDR1, KCNQ4, LHFPL5, LOXHD1, LRTOMT,

MARVELD2, MIRN96, MSRB3, MYH14, MYH9, MYO15A,

MYO1A, MYO3A, MYO6, MYO7A, OTOA, OTOF, PCDH15,

POU3F4, POU4F3, PRPS1, PTPRQ, RDX, SERPINB6,

SLC17A8, SLC26A4, SLC26A5, SMAC, SMPX, STRC,

TECTA, TJP2, TMC1, TMIE, TMPRSS3, TPRN, TRIOBP,

USH1C, USH2A, WFS1, WHRN)

Platform Thermo Fisher Scientific [Ion PGM, Ion Proton, Ion S5]
Library Source gDNA extracted from peripheral blood cells
Cell Lines -
Library Construction (kit name) Ion AmpliSeq Custom kit, Ion AmpliSeq Library Kit ver 2.0
Fragmentation Methods -
Spot Type Single-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 200 bp
DDBJ Sequence Read Archive ID

JGAD000275

JGAD000285

JGAD000286

JGAD000434

JGAD000607

Total Data Volume

JGAD000275:14.3 GB(fastq)

JGAD000285:2 GB(fastq)

JGAD000286:57 GB(fastq)

JGAD000434:8.8 GB(fastq)

JGAD000607:1.1 TB(fastq)

Comments (Policies) NBDC policy

 

DATA PROVIDER

Principal Investigator: Shin-ichi Usami

Affiliation: Department of Hearing Implant Sciences, Shinshu University School of Medicine

Funds / Grants (Research Project Number):

NameTitleProject Number
Health and Labour Sciences Research Grant for Research on Rare and Intractable Diseases Research and Survey for Usher syndrome H22-Nanchi-Ippan-058
Health and Labour Sciences Research Grant for Research on Rare and Intractable Diseases Research and Survey for Inherited Hearing Loss and Inner-, Middle- and Outer Ear Malfolmation H24-Nanchi(Nan)-Ippan-032
Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare Development and Clinical Application of NGS Based Genetic Testing for Deafness H25-Kankaku-Ippan-002
Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare Research and Survey for Intractable Hearing Loss H26-Nanchitou(Nan)-Ippan-032
Practical Research Project for Rare / Intractable Diseases, Japan Agency for Medical Research and Development Development of evidence based treatments for inherited hearing loss JP16ek0109114
Program for an Integrated Database of Clinical and Genomic Information, Japan Agency for Medical Research and Development Development of unified data storage (DS) of clinical and genomic information for sensory disorders JP16kk0205010
Practical Research Project for Rare / Intractable Diseases, Japan Agency for Medical Research and Development Development of evidence based clinical management for hereditary hearing loss. JP18ek0109363
Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare Research and Survey for Intractable Hearing Loss H29-Nanchitou(Nan)-Ippan-031
Health and Labour Sciences Research Grant for Comprehensive Research on Disability Health and Welfare Research and Survey for Intractable Hearing Loss 20FC1048
Research and Development Grants for Comprehensive Research for Persons with Disabilities, Japan Agency for Medical Research and Development Research on building a treatment and rehabilitation system for childhood hearing loss based on causal diagnosis. JP16dk0310067
Practical Research Project for Rare / Intractable Diseases, Japan Agency for Medical Research and Development Development of evidence based clinical management for syndromic hearing loss. JP21ek0109542

 

PUBLICATIONS

TitleDOIDataset ID
1 Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1. doi: 10.1371/journal.pone.0090688 DRA001273
2 An effective screening strategy for deafness in combination with a next-generation sequencing platform: a consecutive analysis. doi: 10.1038/jhg.2015.143 JGAD000032
3 Frequency of Usher syndrome type 1 in deaf children by massively parallel DNA sequencing. doi: 10.1038/jhg.2015.168 DRA003791
4 POU4F3 mutation screening in Japanese hearing loss patients: Massively parallel DNA sequencing-based analysis identified novel variants associated with autosomal dominant hearing loss doi: 10.1371/journal.pone.0177636

JGAD000093

JGAD000607 (69 genes63 genes)

5 WFS1 mutation screening in a large series of Japanese hearing loss patients: Massively parallel DNA sequencing-based analysis. doi: 10.1371/journal.pone.0193359

JGAD000134 (69 genes90 genes)

JGAD000607 (69 genes63 genes)

6 OTOF mutation analysis with massively parallel DNA sequencing in 2,265 Japanese sensorineural hearing loss patients. doi: 10.1371/journal.pone.0215932

JGAD000244 (69 genes90 genes)

JGAD000607 (69 genes63 genes)

7 Detailed Clinical Features of Deafness Caused by a Claudin-14 Variant. doi: 10.3390/ijms20184579 JGAD000274
8 Mutational Spectrum and Clinical Features of Patients with LOXHD1 Variants Identified in an 8074 Hearing Loss Patient Cohort. doi: 10.3390/genes10100735 JGAD000275 (69 genes63 genes90 genes)
9 Mid-Frequency Hearing Loss Is Characteristic Clinical Feature of OTOA-Associated Hearing Loss. doi: 10.3390/genes10090715 JGAD000285
10 The Prevalence and Clinical Characteristics of TECTA-Associated Autosomal Dominant Hearing Loss. doi: 10.3390/genes10100744 JGAD000286 (69 genes63 genes90 genes)
11 Prevalence and Clinical Characteristics of Hearing Loss Caused by MYH14 Variants. doi: 10.3390/genes12101623 JGAD000434 (69 genes63 genes90 genes)
12 Simple and efficient germline copy number variant visualization method for the Ion AmpliSeq™ custom panel. doi: 10.1002/mgg3.399 JGAD000607 (69 genes63 genes)
13 The Clinical Next-Generation Sequencing Database: A Tool for the Unified Management of Clinical Information and Genetic Variants to Accelerate Variant Pathogenicity Classification. doi: 10.1002/humu.23160 JGAD000607 (69 genes63 genes)
14 Frequency and clinical features of hearing loss caused by STRC deletions. doi: 10.1038/s41598-019-40586-7 JGAD000607 (69 genes63 genes)
15 Diagnostic pitfalls for GJB2-related hearing loss: A novel deletion detected by Array-CGH analysis in a Japanese patient with congenital profound hearing loss. doi: 10.1002/ccr3.1800 JGAD000607 (69 genes63 genes)
16 Sensorineural hearing loss and mild cardiac phenotype caused by an EYA4 mutation. doi: 10.1038/s41439-018-0023-9 JGAD000607 (69 genes63 genes)
17 Frequency of the STRC-CATSPER2 deletion in STRC-associated hearing loss patients. doi: 10.1038/s41598-021-04688-5 JGAD000607 (69 genes63 genes)
18 Variants in CDH23 cause a broad spectrum of hearing loss: from non-syndromic to syndromic hearing loss as well as from congenital to age-related hearing loss. doi: 10.1007/s00439-022-02431-2 JGAD000607 (69 genes63 genes)
19 Genetic background in late-onset sensorineural hearing loss patients. doi: 10.1038/s10038-021-00990-2 JGAD000607 (69 genes63 genes)
20 The genetic etiology of hearing loss in Japan revealed by the social health insurance-based genetic testing of 10K. doi: 10.1007/s00439-021-02371-3 JGAD000607 (69 genes63 genes)
21 Detailed clinical features and genotype-phenotype correlation in an OTOF-related hearing loss cohort in Japan. doi: 10.1007/s00439-021-02351-7 JGAD000607 (69 genes63 genes)
22 Prevalence and clinical features of autosomal dominant and recessive TMC1-associated hearing loss. doi: 10.1007/s00439-021-02364-2 JGAD000607 (69 genes63 genes)
23 Human deafness-associated variants alter the dynamics of key molecules in hair cell stereocilia F-actin cores. doi: 10.1007/s00439-021-02304-0 JGAD000607 (69 genes63 genes)
24 Identification of a Novel Copy Number Variation of EYA4 Causing Autosomal Dominant Non-syndromic Hearing Loss. doi: 10.1097/MAO.0000000000003169 JGAD000607 (69 genes63 genes)
25 Novel ACTG1 mutations in patients identified by massively parallel DNA sequencing cause progressive hearing loss. doi: 10.1038/s41598-020-63690-5 JGAD000607 (69 genes63 genes)
26 Clinical Characteristics and In Vitro Analysis of MYO6 Variants Causing Late-Onset Progressive Hearing Loss. doi: 10.3390/genes11030273 JGAD000607 (69 genes63 genes)
27 Prevalence and clinical features of hearing loss caused by EYA4 variants. doi: 10.1038/s41598-020-60259-0 JGAD000607 (69 genes63 genes)
28 Cochlear Implantation From the Perspective of Genetic Background. doi: 10.1002/ar.24360 JGAD000607 (69 genes63 genes)

 

USRES (Controlled-access Data)

Principal InvestigatorAffiliationResearch TitleData in Use (Dataset ID)Period of Data Use